Imperial College London

DrSanjayPopat

Faculty of MedicineNational Heart & Lung Institute

Reader in Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 7808 2132s.popat Website

 
 
//

Location

 

Royal Marsden HospitalThe Royal Marsden Hospital

//

Summary

 

Publications

Citation

BibTex format

@article{Popat:2021:10.1016/j.lungcan.2021.09.009,
author = {Popat, S and Jung, HA and Lee, SY and Hochmair, MJ and Lee, SH and Escriu, C and Lee, MK and Migliorino, MR and Lee, YC and Girard, N and Daoud, H and Marten, A and Miura, S},
doi = {10.1016/j.lungcan.2021.09.009},
journal = {LUNG CANCER},
pages = {9--15},
title = {Sequential afatinib and osimertinib in patients with <i>EGFR</i> mutation-positive NSCLC and acquired T790M: A global non-interventional study (UpSwinG)},
url = {http://dx.doi.org/10.1016/j.lungcan.2021.09.009},
volume = {162},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Popat,S
AU - Jung,HA
AU - Lee,SY
AU - Hochmair,MJ
AU - Lee,SH
AU - Escriu,C
AU - Lee,MK
AU - Migliorino,MR
AU - Lee,YC
AU - Girard,N
AU - Daoud,H
AU - Marten,A
AU - Miura,S
DO - 10.1016/j.lungcan.2021.09.009
EP - 15
PY - 2021///
SN - 0169-5002
SP - 9
TI - Sequential afatinib and osimertinib in patients with <i>EGFR</i> mutation-positive NSCLC and acquired T790M: A global non-interventional study (UpSwinG)
T2 - LUNG CANCER
UR - http://dx.doi.org/10.1016/j.lungcan.2021.09.009
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000708647200002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 162
ER -